Different anthracycline derivates for reducing cardiotoxicity in cancer patients by van Dalen Elvira C, Michiels Erna Mc, Caron Huib N, Kremer Leontien Cm in Cochrane database of systematic reviews (Online) (2010).

[PMID: 20238335] PubMed


The use of anthracyclines is limited by the occurrence of cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline derivates have been studied.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.